4 research outputs found

    Evaluation of the Usefuness of Youtube Videos as Sources Related to Vitrectomy in Vitreous Hemorrhage

    No full text
    Objective: To evaluate the usefulness of YouTube videos about vitrectomy in vitreous hemorrhage surgery as a resource. Methods: The first 100 videos were evaluated when they were scanned by typing "vitreous hemorrhage vitrectomy" in the YouTube search engine. These videos were also analyzed and scored using DISCERN, Journal of the American Medical Association (JAMA) and Global Quality (GQ) scoring systems. Results: The DISCERN score of the evaluated videos was 37.2 ±6.5; JAMA score 1.9 ± 0.5; The GQ score was 2.0 ± 0.5. According to the results, vitrectomy in vitreous hemorrhage surgery videos, DISCERN score is weak; The JAMA score was evaluated as low quality and poor quality in the GQ score. Conclusion: Although there are enough videos on YouTube with vitrectomy in vitreous hemorrhage, its usefulness as a resource is low and its quality is poor

    Vitreoretinal Surgery for Intraocular Lens Dislocated into the Vitreous Cavity

    No full text
    Objectives: To investigate the sex, age, accompanying eye examination findings, and the outcomes of vitreoretinal surgery (VRS) for intraocular lens (IOL) dislocated into the vitreous cavity. Materials and Methods: The medical records of 30 patients who underwent VRS for IOL dislocation into the vitreous cavity were retrospectively analyzed in this study. Preoperative and postoperative visual acuity, intraocular pressure, biomicroscopic, and posterior segment examination findings were assessed. Results: The average age of the patients was 63.1 (range: 38-83) years. Twenty-one patients were male (70%) and 9 patients were female (30%). As etiologic causes, 18 cases (60%) had late spontaneous dislocation, 5 cases (16.6%) had dislocation after phacoemulsification surgery, 4 cases (13.3%) had trauma, 2 cases (6.6%) had previously undergone vitrectomy, and 1 case (3.3%) had undergone YAG laser capsulotomy. VRS including 23-gauge triamcinolone-assisted pars plana vitrectomy, intraocular lens extraction, posterior hyaloid membrane removing, endolaser photocoagulation, and fluid-air exchange was performed. Posterior chamber IOL implantation on to the anterior capsule in 13 cases (43.3%), anterior chamber IOL implantation in 10 cases (33.3%), and scleral fixated posterior IOL implantation in 4 cases (13.3%) were performed. The corrected visual acuity recorded at the last follow-up was better than the first visit in 23 cases (76.6%), the same in 5 eyes (16.6%), and worse in 2 eyes (6.6%). Conclusion: VRS combined IOL implantation is a successful surgery method for IOL dislocated into the vitreous cavity and can avoid poor visual outcomes. (Turk J Ophthalmol 2015; 45: 56-9

    The efficiency of pamidronate treatment on children with osteogenesis imperfecta

    No full text
    Osteogenezis imperfekta düşük kemik kitlesi ve artmış kemik frajilitesi ile karakterize ektraselüler matriksin genetik bir hastalığıdır. Sodyum bifosfonat tedavisi ile osteogenezis imperfektalı hastaların çoğunda kemik dansitesinde hızlı bir artış, kronik kemik ağrılarında ve kırık sayısında azalma ile mobilitede iyileşme sağlanmaktadır. Bu çalışmaya siklik bifosfonat tedavisi alan 16’sı kız toplam 31 osteogenezis imperfektalı çocuk alındı. Hastaların ortalama yaşları 8.80±5.04 yıl olup dokuzu tip 1, 11’i tip 3 ve 11’i tip 4 olarak değerlendirildi. Hastalar ortalama 3.43±1.91 yıl süreyle (9 ay - 6 yıl), ortalama 12,2 mg/kg/yıl dozunda ve 2-4 aylık dönemler halinde bifosfonat tedavisi aldılar. Tedavi öncesi hastaların sekizinde 15 ve üstü sayıda kırık oluşmuştu. Tedavi öncesi kırık sayıları yıllık ortalama 7.45±5.33 iken tedavi ile bu sayı 1.70±1.90/ yıl’a geriledi. Tip 1 ve Tip 4 olarak değerlendirilen hastalardan 10’unda tedavi sonrası hiç kırık gözlenmezken iki hastanın tedavi ile kırık sayılarında herhangi azalma olmadı. Pamidronat tedavisi ile kemik mineral yoğunluğu Z skorlarında ilk 3 yıl artış gözlenirken sonraki yıllarda bu artışın durduğu ve yıllar içinde bir miktar azaldığı saptandı. Pamidronat tedavisi ile kas gücünde artış, yürüme fonksiyonunda düzelme gözlenirken boy SDS’lerinde herhangi bir değişiklik izlenmedi. Sonuç olarak osteogenezis imperfektalı çocuklarda pamidronat tedavisi ile kemik mineral yoğunluğunda artış, kırık sayısında ve ağrıda belirgin azalma ve mobilitede artış sağlanması ile yaşam kalitesinde belirgin düzelme elde edildiği gözlendi.Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased bone mass, and increased bone fragility. Sodium bisphosphonate treatment leads to a quick increase in bone mineral density with resultant reduced bone pain, fracture rate, and immobility in osteogenesis imperfecta. In this study we evaluated the data of 31 children, of 16 female, aged 8.80±5.04 years, with osteogenesis imperfecta who were treated with cyclic bisphosphonates. Nine patients were diagnosed as type I, eleven were type III, and eleven were type IV. All patients received bisphosphonate at a mean dose of 12.2 mg/kg/year, once every two-four months. Mean duration of this treatment is 3.43±1.91 years (9 months-6 years). Before treatment number of fracture were minimum 15 in eight patients. The number of fracture were decreased to 1.70±1.90 from 7.45±5.33 with bisphosphonate treatment. Although ten patients with osteogenesis imperfecta type I and IV had no fracture after treatment, we did not observe a decrease in the number of fractures in two patients. Bone mineral density Z-scores increased in the first three years of bisphosphonates treatment, however this increment was stopped and decreased slow rate in the following years. Ambulation scores and muscle were decreased in all patients. We did not observe any beneficial effects of bisphosphonates on the height SDS. In conclusions our data demonstrated that bisphosphonates have dramatically beneficial effect on bone mineral density, rate of fracture, bone pain, and mobility, which leads a higher quality of life in children with osteogenesis imperfecta

    Association between ocular trauma and attention‑deficit/hyperactivity disorder in adult patients

    No full text
    Purpose: To investigate the potential relationship between ocular trauma and attention-deficit/hyperactivity disorder (ADHD)-related clinical outcomes in adults. Methods: This prospective case-control study included 108 ocular trauma patients and 90 age-sex-matched healthy control. The ocular trauma group was separated into the subgroups home accident, outdoor activity, and work related in terms of the reasons for ocular trauma, and as ocular surface problems, blunt trauma-related, and open globe injury in terms of the clinical findings. The ADHD-related clinical outcomes were evaluated using the Wender-Utah Rating Scale (WURS). The outcomes were compared between ocular trauma and control groups, and ocular trauma subgroups. Results: The demographic characteristics of ocular trauma groups and controls were similar (P > 0.05, for all). In comparison to the control group, the ocular trauma group had higher total WURS score and WURS subscale scores, but not significantly (P > 0.05, for all). According to comparisons of the subgroups separated by the reasons, there was significant difference in the mean behavioral problems/impulsivity scores in favor of outdoor activities (P = 0.015). On the other hand, the mean scores for WURS subscales of the subgroups separated by the clinical findings were similar (P > 0.05, for all). Conclusion: WURS scores in ocular trauma patients are similar to control; however, the score in behavioral problems/impulsivity subscales is higher for ocular trauma caused by outdoor activities
    corecore